|Print Page Close Window|
|DURECT CORP filed this Form 10-Q on 11/08/2018|
Confidential treatment has been sought for portions of this agreement. The copy filed herewithin omits the information subject to the confidential treatment request. Omissions are designated as ***. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
IN WITNESS WHEREOF, the parties hereto have executed this Amendment in duplicate originals by their authorized officers as of the Effective Date of the Amendment.
By:/s/ James E. BrownBy:/s/ Ivelina Metcheva
Name:James E. Brown, D.V.MName:Ivelina Metcheva Phd, MBA
Title:CEO Title: President
Date: March 6, 2018Date: March 8, 2018